Zhejiang Taimei Medical Technology Co., Ltd. (FRA:A2V)

Market Cap	273.53M +4.2%
Revenue (ttm)	68.55M +1.8%
Net Income	-8.40M
EPS	-0.02
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.4620
Previous Close	0.4680
Day's Range	0.4580 - 0.4620
52-Week Range	0.3780 - 0.8100
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 26, 2026

About FRA:A2V

Zhejiang Taimei Medical Technology Co., Ltd. provides digital solutions for life sciences research, development, and commercialization in Mainland China and internationally. The company offers Wiz.AI, an AI platform for clinical trials; TrialOS pharmaceutical R&D collaboration platform; PharmaOS, a pharmaceutical digital marketing platform; and the enterprise-medical academic interaction platform. It also provides pharmaceutical R&D solutions comprising eCollect, eBalance, eCooperate, eArchives, eImage medical imaging evaluation system, eSMS si...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2013
• Employees: 687
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: A2V

Financial Performance

In 2025, FRA:A2V's revenue was 512.54 million, a decrease of -7.01% compared to the previous year's 551.16 million. Losses were -42.85 million, -80.04% less than in 2024.

Financial numbers in CNY

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error